High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes
NCT00463892 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2014-11-11
Summary
The study is designed to see if a high-resolution MRI scan of lymph node areas near where a melanoma has been removed from the skin can pick up the spread of melanoma to those lymph nodes with a high degree of accuracy.
Conditions
Interventions
- PROCEDURE
-
High-resolution contrast-enhanced MRI scan
High-resolution contrast-enhanced MRI scan of regional lymph nodes every 6 months on study
Sponsors & Collaborators
-
Redwood Regional Medical Group
lead OTHER
Principal Investigators
-
Peter Brett, M.D. · Redwood Regional Medical Group
-
David Feinberg, M.D., Ph.D. · Redwood Regional Medical Group
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2011-11-30
- Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
Nuclear and Near-Infrared (NIR) Imaging in Melanoma
NCT01295931 ·Status: COMPLETED ·Phase: PHASE1
-
One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy
NCT06809491 ·Status: ACTIVE_NOT_RECRUITING
-
Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)
NCT02434107 ·Status: COMPLETED ·Phase: NA
-
IL2 Imaging in Metastatic Melanoma
NCT02922283 ·Status: TERMINATED ·Phase: NA
-
Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma
NCT03683550 ·Status: UNKNOWN ·Phase: NA
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
NCT00391300 ·Status: UNKNOWN ·Phase: PHASE1
-
Feasibility and Functionality of fPAM Imaging in Melanoma
NCT00776945 ·Status: TERMINATED
-
Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy
NCT04904120 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Efficacy of Patients With Four and More Symptomatic Brain Metastases of Melanoma
NCT03728465 ·Status: TERMINATED ·Phase: PHASE2
-
Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG
NCT05467137 ·Status: UNKNOWN ·Phase: PHASE4
-
Minimally Invasive Groin Dissection for Melanoma
NCT01500304 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
NCT05704647 ·Status: RECRUITING ·Phase: PHASE2
-
Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT03297463 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
NCT04581382 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma
NCT01898403 ·Status: COMPLETED ·Phase: NA
-
Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker
NCT02740920 ·Status: TERMINATED ·Phase: PHASE2
-
Inducing Systemic Immunity and Regressions in Metastatic Melanoma
NCT02350972 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of Infrared Imaging of Cutaneous Melanoma
NCT00937690 ·Status: COMPLETED
-
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
NCT03356470 ·Status: COMPLETED
-
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma
NCT00847522 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
NCT00942162 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
NCT00040352 ·Status: RECRUITING
-
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
NCT03842943 ·Status: RECRUITING ·Phase: PHASE2
-
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
NCT03728842 ·Status: ACTIVE_NOT_RECRUITING